CHMP Positive on Glaxo’s Two Drugs
GlaxoSmithKline announced that two chronic obstructive pulmonary disease COPD drugs Incruse and Anoro have received a positive opinion from the European Medicines Agency’s EMA Committee for Medicinal Products for Human Use CHMP. A final decision from the European Commission should be out by the end of the next quarter. Glaxo […]